Texture and Color Enhancement Imaging (TXI) for Inflammation Assessment in Patients With Inflammatory Bowel Diseases

In the context of the COLORIZE study, it is being tested whether the endoscopic light mode Texture and Color Enhancement Imaging (TXI) is non-inferior to the standard White Light Endoscopy (WLE) in assessing inflammatory activity in patients with Inflammatory Bowel Disease (IBD). For this purpose, ileocolonoscopy is performed on patients diagnosed with IBD, and standardized image documentation will be carried out in both WLE and TXI modes. Step biopsies are taken, and clinically validated, endoscopic, and histological scores are used.

NCT Number	NCT06892990
Lead Sponsor	University of Ulm
Conditions	Inflammatory Bowel Diseases, Colitis, Ulcerative, Crohn Disease
Enrollment	80 participants
Start Date	2024-05-08
Primary Completion	2025-03-31 (estimated)
Study Completion	2025-09 (estimated)
Updated on ClinicalTrials.gov	2025-05-02